Antibody titers of PEG-PLA block copolymer nanosphere containing chimeric recombinant protein of protective antigen and lethal factor of Bacillus anthracis
Authors
Abstract:
Introduction: To date, many vaccines have been developed for anthrax but not yet an ideal vaccine. In this study, chimeric protein containing domain 1 lethal factor and domain 4 protective antigens of Bacillus anthracis in copolymer nanocapsules were used to solve the problems caused by existing vaccines and to increase the efficiency of the proposed vaccine. Materials and Methods: In this experimental study, dual solvent evaporation method was used to produce nanocapsules containing chimeric recombinant protein of protective antigen and lethal factor of Bacillus anthracis. Zeta potential of nanoparticles, nanoparticle loading efficiency, recombinant protein release pattern, potential effect of poly (lactic acid)- poly (ethylene glycol) nanoparticle (PLA-PEG) production on the viability of recombinant proteins were investigated. Mice were used as test and control samples for antibody production and immune response evaluation. Results: The mean antibody titer produced against chimeric proteins loading was significantly different from that of free antigens. Correspondingly, the difference in antibody titer was significant between the groups of one and two times’ injection of loading and free antigens and the most antibody titer was related to two times injections of loading antigens. In addition, there was a significant difference between one times injection of loading and the free antigens. This suggests that the loading chimeric antigen on PLA-PEG nanoparticles and one time injection (instead of four times injections) could produce more antibodies. Conclusion: The results of this study showed that the domain 4 protective antigens and the domain 1 lethal factor of Bacillus anthracis could chimeric with each other and produced the active antigen. This chimeric antigen (LFD1-PA4) is active and able to inducing the animal's immune system. In addition, nanocarriers containing controlled release antigens can induce the immune system of the animal.
similar resources
Evaluation of immune response to recombinant Bacillus anthracis LFD1-PA4 chimeric protein
Background: Anthrax is a particularly dangerous infectious disease that affects humans and livestock. Efficacious vaccines that can rapidly induce a long-term immune response are required to prevent anthrax infection in humans. Domains 4 and 1 of the protective antigen (PA) and lethal factor (LF), respectively, have very high antigenic properties. Aims: In this...
full textC-CfTXA-STxB chimeric antigen loading in PLA-PEG-PLA tri-block copolymers and its immunization in mice
Introduction: The venom of Jellyfish venom contains a variety of bioactive proteins that can be studied for vaccine application. Poly-Lactic Acid is a biodegradable polymer that is used in vaccine systems. The aim of this study was to encapsulate the C-CfTX1-STxB protein into PLA-PEG-PLA three-block copolymer and its immunogenicity study in mice. Materials and Methods: After purification, the p...
full textPreparation and Evaluation of Human-Murine Chimeric Antibody against Protective Antigen of Bacillus anthracis
The aim of this research is to develop a human/murine chimeric Fab antibody which neutralizes the anthrax toxin, protective antigen (PA). The chimeric Fab was constructed using variable regions of murine anti-PA monoclonal antibody in combination with constant regions of human IgG. The chimeric PA6-Fab was expressed in E. coli. BL21 and evaluated by ELISA and co-immunoprecipitation- mass spectr...
full textIn-silico Design and Antibody Response to the Peptide Sequences from Protective Antigen and Lethal Factor Toxins of Bacillus anthracis
Bacillus anthracis is the only pathogen known to be highly infectious with potential biothreat in the family Bacillaceae. The organism in its endospore form has the potential to get aerosolized and infect large population resulting in panic and mass causality (Wilkening, 2006). Because of this reason, Center for Disease control and prevention (CDC) has listed Bacillus anthracis as category A ag...
full textCorrelation between lethal toxin-neutralizing antibody titers and protection from intranasal challenge with Bacillus anthracis Ames strain spores in mice after transcutaneous immunization with recombinant anthrax protective antigen.
Transcutaneous immunization of mice with recombinant protective antigen (rPA) of Bacillus anthracis resulted in significantly higher lethal toxin-neutralizing antibody titers than did intramuscular injection of alum-adsorbed rPA. Immunized mice were partially protected against intranasal challenge with 235,000 (10 50% lethal doses) Ames strain B. anthracis spores. A highly significant correlati...
full textCrystallization of the protective antigen protein of Bacillus anthracis.
The protective antigen protein, one of the three separate proteins constituting the exotoxin system of Bacillus anthracis, has been crystallized in a form suitable for structural studies. The crystal form which is most amenable to x-ray analysis is orthorhombic, space group P2(1)2(1)2(1), a = 101.1 A, b = 95.4 A, c = 87.3 A, with one protective antigen monomer/asymmetric unit. The crystals diff...
full textMy Resources
Journal title
volume 23 issue 4
pages 441- 448
publication date 2021-07
By following a journal you will be notified via email when a new issue of this journal is published.
No Keywords
Hosted on Doprax cloud platform doprax.com
copyright © 2015-2023